{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:57:33Z","timestamp":1776185853273,"version":"3.50.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61672113"],"award-info":[{"award-number":["61672113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61972422"],"award-info":[{"award-number":["61972422"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61672541"],"award-info":[{"award-number":["61672541"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Drug combinations have demonstrated high efficacy and low adverse side effects compared to single drug administration in cancer therapies and thus have drawn intensive attention from researchers and pharmaceutical enterprises. Due to the rapid development of high-throughput screening (HTS), the number of drug combination datasets available has increased tremendously in recent years. Therefore, there is an urgent need for a comprehensive database that is crucial to both experimental and computational screening of synergistic drug combinations. In this paper, we present DrugCombDB, a comprehensive database devoted to the curation of drug combinations from various data sources: (i) HTS assays of drug combinations; (ii) manual curations from the literature; and (iii) FDA Orange Book and external databases. Specifically, DrugCombDB includes 448 555 drug combinations derived from HTS assays, covering 2887 unique drugs and 124 human cancer cell lines. In particular, DrugCombDB has more than 6000 000 quantitative dose responses from which we computed multiple synergy scores to determine the overall synergistic or antagonistic effects of drug combinations. In addition to the combinations extracted from existing databases, we manually curated 457 drug combinations from thousands of PubMed publications. To benefit the further experimental validation and development of computational models, multiple datasets that are ready to train prediction models for classification and regression analysis were constructed and other significant related data were gathered. A website with a user-friendly graphical visualization has been developed for users to access the wealth of data and download prebuilt datasets. Our database is available at http:\/\/drugcombdb.denglab.org\/.<\/jats:p>","DOI":"10.1093\/nar\/gkz1007","type":"journal-article","created":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T19:37:24Z","timestamp":1571341044000},"source":"Crossref","is-referenced-by-count":105,"title":["DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy"],"prefix":"10.1093","author":[{"given":"Hui","family":"Liu","sequence":"first","affiliation":[{"name":"Lab of Information Management, Changzhou University, Changzhou 213164, China"}]},{"given":"Wenhao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Lab of Information Management, Changzhou University, Changzhou 213164, China"}]},{"given":"Bo","family":"Zou","sequence":"additional","affiliation":[{"name":"School of Computer Science and Engineering, Central South University, Changsha 410075, China"}]},{"given":"Jinxian","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Computer Science and Engineering, Central South University, Changsha 410075, China"}]},{"given":"Yuanyuan","family":"Deng","sequence":"additional","affiliation":[{"name":"School of Computer Science and Engineering, Central South University, Changsha 410075, China"}]},{"given":"Lei","family":"Deng","sequence":"additional","affiliation":[{"name":"School of Computer Science and Engineering, Central South University, Changsha 410075, China"},{"name":"School of Software, Xinjiang University, Urumqi 830008, China"}]}],"member":"286","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"2019103013404322900_B1","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Caitriona","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"2019103013404322900_B2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Michael","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"2019103013404322900_B3","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/bioinformatics\/btu046","article-title":"Combinatorial therapy discovery using mixed integer linear programming","volume":"30","author":"Pang","year":"2014","journal-title":"Bioinformatics"},{"key":"2019103013404322900_B4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-pharmtox-010715-103111","article-title":"Toward a better understanding of the complexity of cancer drug resistance","volume":"56","author":"Michael","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2019103013404322900_B5","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","article-title":"Network-based prediction of drug combinations","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"2019103013404322900_B6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd2683","article-title":"Mechanisms of drug combinations: interaction and network perspectives","volume":"8","author":"Jia","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"2019103013404322900_B7","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Bissan","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"2019103013404322900_B8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","article-title":"The efficiency of multi-target drugs: the network approach might help drug design","volume":"26","author":"P\u00e9ter","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"2019103013404322900_B9","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-10-0460","article-title":"Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis","volume":"70","author":"Sergio","year":"2010","journal-title":"Cancer Res."},{"key":"2019103013404322900_B10","doi-asserted-by":"crossref","first-page":"e1003226","DOI":"10.1371\/journal.pcbi.1003226","article-title":"Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways","volume":"9","author":"Tang","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"2019103013404322900_B11","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2012.03.031","article-title":"Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks","volume":"149","author":"Michael","year":"2012","journal-title":"Cell"},{"key":"2019103013404322900_B12","doi-asserted-by":"crossref","first-page":"D1011","DOI":"10.1093\/nar\/gkv1108","article-title":"SynLethDB: synthetic lethality database toward discovery of selective and sensitive anticancer drug targets","volume":"44","author":"Guo","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"2019103013404322900_B13","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/nbt.2877","article-title":"A community effort to assess and improve drug sensitivity prediction algorithms","volume":"32","author":"James","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"2019103013404322900_B14","doi-asserted-by":"crossref","first-page":"205rv1","DOI":"10.1126\/scitranslmed.3006667","article-title":"High-throughput methods for combinatorial drug discovery","volume":"5","author":"Sun","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"2019103013404322900_B15","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.3390\/genes10020087","article-title":"Machine learning and integrative analysis of biomedical big data","volume":"10","author":"Bilal","year":"2019","journal-title":"Genes"},{"key":"2019103013404322900_B16","doi-asserted-by":"crossref","first-page":"bau124","DOI":"10.1093\/database\/bau124","article-title":"DCDB2.0: a major update of the drug combination database","volume":"2014","author":"Liu","year":"2014","journal-title":"Database"},{"key":"2019103013404322900_B17","doi-asserted-by":"crossref","first-page":"W43","DOI":"10.1093\/nar\/gkz337","article-title":"DrugComb: an integrative cancer drug combination data portal","volume":"47","author":"Bulat","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"2019103013404322900_B18","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1158\/0008-5472.CAN-17-0489","article-title":"The National Cancer Institute ALMANAC: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity","volume":"77","author":"Susan","year":"2017","journal-title":"Cancer Res."},{"key":"2019103013404322900_B19","doi-asserted-by":"crossref","first-page":"eaan4470","DOI":"10.1126\/scitranslmed.aan4470","article-title":"MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma","volume":"10","author":"Marielle","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"2019103013404322900_B20","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","article-title":"An unbiased oncology compound screen to identify novel combination strategies","volume":"15","author":"O'Neil","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"2019103013404322900_B21","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1073\/pnas.1311846111","article-title":"High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell\u2013like diffuse large B-cell lymphoma cells","volume":"111","author":"Mathews\u00a0Griner","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2019103013404322900_B22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.15252\/msb.20166796","article-title":"Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de-differentiated state","volume":"13","author":"Mohammad","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"2019103013404322900_B23","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/s41467-019-09799-2","article-title":"Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen","volume":"10","author":"Michael","year":"2019","journal-title":"Nat. Commun."},{"key":"2019103013404322900_B24","doi-asserted-by":"crossref","first-page":"W518","DOI":"10.1093\/nar\/gkt441","article-title":"PubTator: a web-based text mining tool for assisting biocuration","volume":"41","author":"Wei","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2019103013404322900_B25","first-page":"D963","article-title":"DrugCentral 2018: an update","volume":"47","author":"Oleg","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2019103013404322900_B26","doi-asserted-by":"crossref","first-page":"D1121","DOI":"10.1093\/nar\/gkx1076","article-title":"Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics","volume":"46","author":"Li","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2019103013404322900_B27","doi-asserted-by":"crossref","first-page":"e86499","DOI":"10.1371\/journal.pone.0086499","article-title":"ASDCD: antifungal synergistic drug combination database","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"2019103013404322900_B28","first-page":"D1074","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"David","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2019103013404322900_B29","first-page":"D590","article-title":"New approach for understanding genome variations in KEGG","volume":"47","author":"Minoru","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2019103013404322900_B30","first-page":"D380","article-title":"STITCH 5: augmenting protein\u2013chemical interaction networks with tissue and affinity data","volume":"44","author":"Damian","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"2019103013404322900_B31","first-page":"D1202","article-title":"PubChem substance and compound databases","volume":"44","author":"Sunghwan","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"2019103013404322900_B32","first-page":"D945","article-title":"COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer","volume":"39","author":"Simon","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"2019103013404322900_B33","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1093\/nar\/gkg563","article-title":"ExPASy: the proteomics server for in-depth protein knowledge and analysis","volume":"31","author":"Elisabeth","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"2019103013404322900_B34","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"2019103013404322900_B35","first-page":"93","article-title":"What is synergy","volume":"41","author":"Morris","year":"1989","journal-title":"Pharmacol. Rev."},{"key":"2019103013404322900_B36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"CI","year":"1939","journal-title":"Ann. Appl. Biol."},{"key":"2019103013404322900_B37","first-page":"331","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"William","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"2019103013404322900_B38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for drug synergy in complex dose\u2013response landscapes using an interaction potency model","volume":"13","author":"Bhagwan","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2019103013404322900_B39","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","article-title":"SynergyFinder: a web application for analyzing drug combination dose\u2013response matrix data","volume":"33","author":"Aleksandr","year":"2017","journal-title":"Bioinformatics"},{"key":"2019103013404322900_B40","doi-asserted-by":"crossref","first-page":"e1006752","DOI":"10.1371\/journal.pcbi.1006752","article-title":"Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer","volume":"15","author":"Alina","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"2019103013404322900_B41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"2019103013404322900_B42","doi-asserted-by":"crossref","first-page":"eaaw8412","DOI":"10.1126\/scitranslmed.aaw8412","article-title":"Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials","volume":"11","author":"Lin","year":"2019","journal-title":"Sci. Transl. Med."}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nar\/advance-article-pdf\/doi\/10.1093\/nar\/gkz1007\/30330094\/gkz1007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/nar\/advance-article-pdf\/doi\/10.1093\/nar\/gkz1007\/30330094\/gkz1007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T03:48:07Z","timestamp":1611546487000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/advance-article\/doi\/10.1093\/nar\/gkz1007\/5609522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":42,"URL":"https:\/\/doi.org\/10.1093\/nar\/gkz1007","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"article-number":"gkz1007"}}